9.59
-0.21%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Jiangxi Sanxin Medtec Co
Its shares trade on Shenzhen under the ticker 300453.SZ. It has been listed since 15 May 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.64bn and net income of CN¥262.5m. At that date it held total assets of CN¥2.43bn and shareholders' equity of CN¥1.46bn.
Jiang Xi Sanxin Medtec Co., Ltd. principally engages in the production and sale of single-use sterile infusion and infusion medical devices. The company is headquartered in Nanchang, Jiangxi. The company went IPO on 2015-05-15. The firm's products include five series: syringe series, infusion & transfusion series, catheter tubing series, blood purification series and other series. The firm distributes its products within the domestic markets and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 15 May 2015
- Employees
- 1,877
- Website
- sanxin-med.com ↗
Leadership
Pay as last reported
- Mr. Yixing PengChairman of the BoardCN¥719,900
- Mr. Zhiping MaoPresident, Director, since 2023CN¥677,900
- Ms. Fenglian LeiVice Chairman of the Board, since 2020CN¥677,900
- Mr. Ming LiuActing Chief Financial Officer, Vice President, Secretary of the Board, Director, since 2019CN¥551,500
- Ms. Lingli LengVice President
- Mr. Bingrong LiuVice President
- Ms. Ling PengVice President, since 2023CN¥653,000
- Mr. Ganying WangVice PresidentCN¥470,500
- Mr. Zhenrong LeDirectorCN¥653,000
- Mr. Guofeng ChenIndependent Director
- Mr. Haihong JiangIndependent DirectorCN¥57,000
- Mr. Xiaohua XiaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Jiangxi Sanxin Medtec employs 1,877 full-time employees in Nanchang, CN.
- The company produces five series of medical devices including syringe and infusion products.
- Jiangxi Sanxin Medtec distributes products domestically and internationally across markets.
Weaknesses
- The company's products are limited to single-use sterile infusion medical devices only.
- Jiangxi Sanxin Medtec has no international headquarters outside Nanchang, CN.
- The firm's business is solely focused on domestic and overseas markets without expansion plans.
Opportunities
- The Health Care sector in China offers growth potential for medical device manufacturers.
- Jiangxi Sanxin Medtec can expand its product lines within the domestic market.
- Growing demand for blood purification series products presents new market opportunities.
Threats
- The Health Care industry faces regulatory challenges in China's domestic market.
- Competition from other medical device manufacturers in the Chinese market.
- Overseas market distribution may face trade barriers in international markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.